» Articles » PMID: 36291647

Activation of Nrf2 to Optimise Immune Responses to Intracerebral Haemorrhage

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Oct 27
PMID 36291647
Authors
Affiliations
Soon will be listed here.
Abstract

Haemorrhage into the brain parenchyma can be devastating. This manifests as spontaneous intracerebral haemorrhage (ICH) after head trauma, and in the context of vascular dementia. Randomised controlled trials have not reliably shown that haemostatic treatments aimed at limiting ICH haematoma expansion and surgical approaches to reducing haematoma volume are effective. Consequently, treatments to modulate the pathophysiological responses to ICH, which may cause secondary brain injury, are appealing. Following ICH, microglia and monocyte derived cells are recruited to the peri-haematomal environment where they phagocytose haematoma breakdown products and secrete inflammatory cytokines, which may trigger both protective and harmful responses. The transcription factor Nrf2, is activated by oxidative stress, is highly expressed by central nervous system microglia and macroglia. When active, Nrf2 induces a transcriptional programme characterised by increased expression of antioxidant, haem and heavy metal detoxification and proteostasis genes, as well as suppression of proinflammatory factors. Therefore, Nrf2 activation may facilitate adaptive-protective immune cell responses to ICH by boosting resistance to oxidative stress and heavy metal toxicity, whilst limiting harmful inflammatory signalling, which can contribute to further blood brain barrier dysfunction and cerebral oedema. In this review, we consider the responses of immune cells to ICH and how these might be modulated by Nrf2 activation. Finally, we propose potential therapeutic strategies to harness Nrf2 to improve the outcomes of patients with ICH.

Citing Articles

Exploring the associations of gut microbiota with inflammatory and the early hematoma expansion in intracerebral hemorrhage: from change to potential therapeutic objectives.

Jiang H, Zeng W, Zhu F, Zhang X, Cao D, Peng A Front Cell Infect Microbiol. 2025; 15:1462562.

PMID: 39963412 PMC: 11830820. DOI: 10.3389/fcimb.2025.1462562.


Harshly Oxidized Activated Charcoal Enhances Protein Persulfidation with Implications for Neurodegeneration as Exemplified by Friedreich's Ataxia.

Vo A, Khan U, Liopo A, Mouli K, Olson K, McHugh E Nanomaterials (Basel). 2024; 14(24.

PMID: 39728543 PMC: 11728766. DOI: 10.3390/nano14242007.


Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges.

Gan L, Wang W, Jiang J, Tian K, Liu W, Cao Z Front Immunol. 2024; 15:1429836.

PMID: 39286246 PMC: 11402828. DOI: 10.3389/fimmu.2024.1429836.


[Distribution characteristics and correlation analysis of variation in patients with auditory neuropathy].

Li Y, Wang H, Li D, Wang Q Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(1):23-29.

PMID: 38297845 PMC: 11116162. DOI: 10.13201/j.issn.2096-7993.2024.01.004.


Anti-oxidant effects of cannabidiol relevant to intracerebral hemorrhage.

Yan G, Zhang X, Li H, Guo Y, Yong V, Xue M Front Pharmacol. 2023; 14:1247550.

PMID: 37841923 PMC: 10568629. DOI: 10.3389/fphar.2023.1247550.


References
1.
Satoh T, McKercher S, Lipton S . Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med. 2013; 65:645-657. PMC: 3859717. DOI: 10.1016/j.freeradbiomed.2013.07.022. View

2.
Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

3.
Zhao X, Sun G, Zhang J, Ting S, Gonzales N, Aronowski J . Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2. Stroke. 2015; 46(7):1923-8. PMC: 4480061. DOI: 10.1161/STROKEAHA.115.009398. View

4.
Loan J, Kirby C, Emelianova K, Dando O, Poon M, Pimenova L . Secondary injury and inflammation after intracerebral haemorrhage: a systematic review and meta-analysis of molecular markers in patient brain tissue. J Neurol Neurosurg Psychiatry. 2021; 93(2):126-132. PMC: 8785052. DOI: 10.1136/jnnp-2021-327098. View

5.
Shtaya A, Bridges L, Esiri M, Lam-Wong J, Nicoll J, Boche D . Rapid neuroinflammatory changes in human acute intracerebral hemorrhage. Ann Clin Transl Neurol. 2019; 6(8):1465-1479. PMC: 6689697. DOI: 10.1002/acn3.50842. View